{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:18:23Z","timestamp":1793045903289,"version":"4.5.0"},"reference-count":304,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.05884"],"award-info":[{"award-number":["2020.05884"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015621","name":"Applied Molecular Biosciences Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.addr.2023.114969","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T12:09:38Z","timestamp":1687262978000},"page":"114969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Reviving the interest in the versatile drug nystatin: A multitude of strategies to increase its potential as an effective and safe antifungal agent"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5596-7479","authenticated-orcid":false,"given":"Filipa","family":"Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingos","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2023.114969_b0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: the silent crisis","volume":"7","author":"Kainz","year":"2020","journal-title":"Microb. Cell"},{"key":"10.1016\/j.addr.2023.114969_b0010","unstructured":"N. Hodges, Antibiotics and synthetic antimicrobial agents: their properties and uses, in: N.H. Stephen, P. Denyer, S.P. Gorman, B. Gilmore (Ed.), Hugo and Russell's Pharmaceutical Microbiology 8th Edition, John Wiley & Sons, Ltd., United Kingdom, 2011."},{"key":"10.1016\/j.addr.2023.114969_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1122340","article-title":"Alginate oligosaccharides enhance the antifungal activity of nystatin against candidal biofilms","volume":"13","author":"Powell","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b0020","unstructured":"C.o.N.T.D. Antimicrobial Resistance Division, Global Coordination and Partnership, WHO fungal priority pathogens list to guide research, development and public health action, in: W.H.O. (WHO) (Ed.), 2022."},{"key":"10.1016\/j.addr.2023.114969_b0025","unstructured":"Interim report for the period: January, 2022 \u2013 March 31, 2022, Biosergen AB, Solna, Sweden, 2022."},{"key":"10.1016\/j.addr.2023.114969_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-0711-13-18","article-title":"The polyene antifungals, amphotericin B and nystatin, cause cell death in Saccharomyces cerevisiae by a distinct mechanism to amphibian-derived antimicrobial peptides","volume":"13","author":"Serhan","year":"2014","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.addr.2023.114969_b0035","doi-asserted-by":"crossref","unstructured":"L. Kristanc, B. Bo\u017ei\u010d, Z. Jokhadar \u0160, M.S. Dolenc, G. Gomi\u0161\u010dek, The pore-forming action of polyenes: From model membranes to living organisms, Biochim. Biophys. Acta Biomembr. 1861 (2019) 418\u2013430.","DOI":"10.1016\/j.bbamem.2018.11.006"},{"key":"10.1016\/j.addr.2023.114969_b0040","unstructured":"M.A.C. Richard Finkel, L.X. Cubeddu, Chapter 35 - Antifungal Drugs, Lippincott\u2019s Illustrated Reviews: Pharmacology, 4th edition, Lippincott Williams & Wilkins, 2009."},{"key":"10.1016\/j.addr.2023.114969_b0045","unstructured":"W.H. Organization, WHO Model List of Essential Medicines \u2013 22nd List, Geneva, 2021."},{"key":"10.1016\/j.addr.2023.114969_b0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jddst.2018.12.014","article-title":"A promising nystatin nanocapsular hydrogel as an antifungal polymeric carrier for the treatment of topical candidiasis","volume":"49","author":"AbouSamra","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.addr.2023.114969_b0055","series-title":"Essentials of Medical Pharmacology","first-page":"787","article-title":"Chapter 57 - Antimicrobial Drugs","author":"Tripathi","year":"2013"},{"key":"10.1016\/j.addr.2023.114969_b0060","unstructured":"N.C.f.B. Information, PubChem Compound Summary for CID 6433272, Nystatin, PubChem, 2023."},{"key":"10.1016\/j.addr.2023.114969_b0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/ger.12278","article-title":"Use of nystatin and chlorhexidine in oral medicine: properties, indications and pitfalls with focus on geriatric patients","volume":"34","author":"Scheibler","year":"2017","journal-title":"Gerodontology"},{"key":"10.1016\/j.addr.2023.114969_b0070","unstructured":"G.H. Hanlon, Norman, Antifungal Agents, in: Wiley-Blackwell (Ed.) Essential Microbiology for Pharmacy and Pharmaceutical Science, John Wiley & Sons, Ltd, United Kingdom, 2013."},{"key":"10.1016\/j.addr.2023.114969_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002033.pub2","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","author":"G\u00f8tzsche","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2023.114969_b0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/infdis\/174.3.583","article-title":"Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation","volume":"174","author":"Lumbreras","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2023.114969_b0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/2249-4847.116408","article-title":"Oral nystatin versus intravenous fluconazole as neonatal antifungal prophylaxis: non-inferiority trial","volume":"2","author":"Mersal","year":"2013","journal-title":"J. Clin. Neonatol."},{"key":"10.1016\/j.addr.2023.114969_b0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12887-020-02074-0","article-title":"Oral nystatin prophylaxis to prevent systemic fungal infection in very low birth weight preterm infants: a randomized controlled trial","volume":"20","author":"Rundjan","year":"2020","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.addr.2023.114969_b0095","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2147\/DDDT.S100795","article-title":"Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis","volume":"10","author":"Lyu","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2023.114969_b0100","series-title":"Medical Mycology in the United States: A Historical Analysis (1894\u20131996)","first-page":"49","article-title":"The advent of antifungal and immunosuppressive therapies: 1950 to 1969","author":"Espinel-Ingroff","year":"2003"},{"key":"10.1016\/j.addr.2023.114969_b0105","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1128\/AAC.47.12.3917-3925.2003","article-title":"Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits","volume":"47","author":"Groll","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00253-004-1802-4","article-title":"Biosynthesis of the polyene macrolide antibiotic nystatin in Streptomyces noursei","volume":"67","author":"Fjaervik","year":"2005","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.addr.2023.114969_b0115","first-page":"1215","article-title":"Spectrophotometric method for quantitative determination of Nystatin antifungal agent in pharmaceutical formulations","volume":"9","author":"Rodino","year":"2014","journal-title":"Dig. J. Nanomater. Biostruct."},{"key":"10.1016\/j.addr.2023.114969_b0120","unstructured":"EDQM, General Monographs - Nystatin, in: C.o. Europe (Ed.) European Pharmacopoeia: 11th edition Strasbourg, France, 2019, pp. 0517."},{"key":"10.1016\/j.addr.2023.114969_b0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.15171\/apb.2018.070","article-title":"Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap to Improve Their Therapeutic Index","volume":"8","author":"Kumar","year":"2018","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.addr.2023.114969_b0130","unstructured":"E.M. Agency, ICH M9 guideline on biopharmaceutics classification system-based biowaivers - Stp 5, in: C.f.M.P.f.H. Use (Ed.), 2020."},{"key":"10.1016\/j.addr.2023.114969_b0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2023.114969_b0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/mp100363f","article-title":"Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin","volume":"8","author":"Day","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2023.114969_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4025\/actascihealthsci.v35i2.12769","article-title":"Physical and chemical analysis of commercial nystatin","volume":"35","author":"Brescansin","year":"2013","journal-title":"Acta Scientiarum - Health Sciences"},{"key":"10.1016\/j.addr.2023.114969_b0150","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1016\/S0040-4039(01)80734-6","article-title":"Complete stereostructure of nystatin A1: a proton NMR study","volume":"30","author":"Lancelin","year":"1989","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.addr.2023.114969_b0155","unstructured":"N.C.f.B. Information, PubChem Compound Summary for CID 11286230, Nystatin A1, PubChem, 2023."},{"key":"10.1016\/j.addr.2023.114969_b0160","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/mrc.4478","article-title":"Intramolecular transformation of an antifungal antibiotic nystatin A(1) into its isomer, iso-nystatin A(1) - structural and molecular modeling studies","volume":"54","author":"Szwarc","year":"2016","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.addr.2023.114969_b0165","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.7164\/antibiotics.41.1289","article-title":"The structure of nystatin A3, a component of nystatin complex","volume":"41","author":"Zielinski","year":"1988","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.addr.2023.114969_b0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jpba.2006.04.011","article-title":"Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate","volume":"42","author":"Groeschke","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.addr.2023.114969_b0175","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1517\/17425247.2010.525230","article-title":"Topical delivery of antifungal agents","volume":"7","author":"Kaur","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2023.114969_b0180","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1128\/AAC.41.9.1871","article-title":"Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma","volume":"41","author":"Wasan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0185","unstructured":"N.C.f.B. Information, PubChem Compound Summary for CID 11953998, Nystatin A3, PubChem, 2023."},{"key":"10.1016\/j.addr.2023.114969_b0190","unstructured":"N.C.f.B. Information, PubChem Compound Summary for CID 72941583, Nystatin A2, PubChem, 2023."},{"key":"10.1016\/j.addr.2023.114969_b0195","unstructured":"C.d.A.M.J.R.A.d. Santos, Chapter 11 - Phytochemicals and Their Antifungal Potential Against Pathogenic Yeasts, in: V. Rao (Ed.) Phytochemicals in Human Health, IntechOpen, United Kingdom, 2020."},{"key":"10.1016\/j.addr.2023.114969_b0200","doi-asserted-by":"crossref","unstructured":"D.L.q. Yasmine Nivoix, Raoul Herbrecht, Genevi\u00e8ve Ubeaud-S\u00e9quier, Traitement des infections fongiques invasives et superficielles, in: S.L. Association Nationale des Enseignants de Pharmacie Clinique, Antoine Dupuis, Philippe Fagnoni, B\u00e9atrice Demor\u00e9, Christine Fernandez, Gilles Aulagner, Jean-Louis Cazin (Ed.) Pharmacie clinique et th\u00e9rapeutique, Elsevier Masson 2018, pp. 893\u2013924.","DOI":"10.1016\/B978-2-294-75077-9.00051-7"},{"key":"10.1016\/j.addr.2023.114969_b0205","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3389\/fmicb.2018.01351","article-title":"Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents","volume":"9","author":"Santos","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fmicb.2017.00036","article-title":"Antifungal therapy: new advances in the understanding and treatment of mycosis","volume":"8","author":"Scorzoni","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b0215","doi-asserted-by":"crossref","DOI":"10.3402\/acmo.v2.23955","article-title":"Multidrug resistance ATP-binding cassette membrane transporters as targets for improving oropharyngeal candidiasis treatment","volume":"2","author":"Martinez","year":"2014","journal-title":"Adv. Cell. Mol. Otolaryngol."},{"key":"10.1016\/j.addr.2023.114969_b0220","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004014","article-title":"Drug delivery (nano)platforms for oral and dental applications: tissue regeneration, infection control, and cancer management","volume":"8","author":"Makvandi","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0225","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1046\/j.1432-1033.2002.03147.x","article-title":"Solution NMR structure of five representative glycosylated polyene macrolide antibiotics with a sterol-dependent antifungal activity","volume":"269","author":"Volpon","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.addr.2023.114969_b0230","doi-asserted-by":"crossref","first-page":"30078","DOI":"10.1039\/C7CP05353C","article-title":"The molecular mechanism of Nystatin action is dependent on the membrane biophysical properties and lipid composition","volume":"19","author":"Dos Santos","year":"2017","journal-title":"PCCP"},{"key":"10.1016\/j.addr.2023.114969_b0235","doi-asserted-by":"crossref","first-page":"e0165098","DOI":"10.1371\/journal.pone.0165098","article-title":"Osmotic Effects Induced by Pore-Forming Agent Nystatin: From Lipid Vesicles to the Cell","volume":"11","author":"Zemljic Jokhadar","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2023.114969_b0240","doi-asserted-by":"crossref","unstructured":"G. Quind\u00f3s, S. Gil-Alonso, C. Marcos-Arias, E. Sevillano, E. Mateo, N. Jauregizar, E. Eraso, Therapeutic tools for oral candidiasis: Current and new antifungal drugs, Med. Oral Patol. Oral Cir. Bucal. 24 (2019) e172\u2013e180.","DOI":"10.4317\/medoral.22978"},{"key":"10.1016\/j.addr.2023.114969_b0245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.2042-7158.1973.tb10035.x","article-title":"The effect of pH and of temperature on the stability and bioactivity of nystatin and amphotericin B","volume":"25","author":"Hamilton-Miller","year":"1973","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2023.114969_b0250","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/jof6040321","article-title":"Amphotericin B and other polyenes-discovery, clinical use, mode of action and drug resistance","volume":"6","author":"Carolus","year":"2020","journal-title":"J. Fungi (Basel)"},{"key":"10.1016\/j.addr.2023.114969_b0255","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fmicb.2012.00286","article-title":"It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug","volume":"3","author":"Mesa-Arango","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00249-014-0983-8","article-title":"Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments","volume":"43","author":"Kami\u0144ski","year":"2014","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.addr.2023.114969_b0265","series-title":"Pharmacology and Therapeutics for Dentistry","first-page":"488","article-title":"Chapter 34 - Antifungal and Antiviral Agents","author":"Park","year":"2017"},{"key":"10.1016\/j.addr.2023.114969_b0270","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/IJN.S282305","article-title":"Bursting the virulence traits of MDR strain of Candida albicans using sodium alginate-based microspheres containing nystatin-loaded MgO\/CuO nanocomposites","volume":"16","author":"Abid","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.114969_b0275","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10266-021-00667-4","article-title":"Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study","volume":"110","author":"Ozdal Zincir","year":"2022","journal-title":"Odontology"},{"key":"10.1016\/j.addr.2023.114969_b0280","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1128\/AAC.48.12.4808-4812.2004","article-title":"Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B","volume":"48","author":"Offner","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12275-011-1064-7","article-title":"Candida albicans, a major human fungal pathogen","volume":"49","author":"Kim","year":"2011","journal-title":"J. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b0290","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1288\/00005537-198811000-00005","article-title":"In vitro effectiveness of 13 agents in otomycosis and review of the literature","volume":"98","author":"Stern","year":"1988","journal-title":"Laryngoscope"},{"key":"10.1016\/j.addr.2023.114969_b0295","first-page":"107","article-title":"Some effects of nystatin on the growth of four Aspergillus species","volume":"40","author":"Stanley","year":"1965","journal-title":"Microbiology"},{"key":"10.1016\/j.addr.2023.114969_b0300","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.31.12.1897","article-title":"Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic Candidiasis","volume":"31","author":"Mehta","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0305","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/jb.108.1.69-73.1971","article-title":"Nystatin-resistant mutants of yeast: alterations in sterol content","volume":"108","author":"Woods","year":"1971","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.addr.2023.114969_b0310","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/jb.111.3.649-657.1972","article-title":"Biochemical and genetic aspects of nystatin resistance in saccharomyces cerevisiae","volume":"111","author":"Bard","year":"1972","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.addr.2023.114969_b0315","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1128\/AAC.42.6.1412","article-title":"Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations","volume":"42","author":"Johnson","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/129.1.53","article-title":"Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria","volume":"129","author":"Woods","year":"1974","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2023.114969_b0325","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/jps.20301","article-title":"Polysorbate 80 and Cremophor EL micelles deaggregate and solubilize nystatin at the core-corona interface","volume":"94","author":"Croy","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1439-0507.1991.tb00623.x","article-title":"Polyene resistance in ergosterol producing strains of Candida albicans","volume":"34","author":"Broughton","year":"1991","journal-title":"Mycoses"},{"key":"10.1016\/j.addr.2023.114969_b0335","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jac\/44.3.397","article-title":"In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole","volume":"44","author":"Carrillo-Munoz","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0340","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/jcm.26.12.2626-2631.1988","article-title":"In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus","volume":"26","author":"Korting","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b0345","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0002-9343(88)90059-9","article-title":"Amphotericin B-resistant yeast infection in severely immunocompromised patients","volume":"84","author":"Powderly","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1016\/j.addr.2023.114969_b0350","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/AAC.13.6.914","article-title":"Dissociation between ion permeability and the lethal action of polyene antibiotics on Candida albicans","volume":"13","author":"Chen","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0355","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1128\/AAC.43.5.1264","article-title":"Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole","volume":"43","author":"Oakley","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0360","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/00220345010800031101","article-title":"Antifungal resistance of candidal biofilms formed on denture acrylic in vitro","volume":"80","author":"Chandra","year":"2001","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.addr.2023.114969_b0365","first-page":"347","article-title":"Antimicrobial effect of copper oxide nanoparticles on some oral bacteria and Candida species","volume":"4","author":"Amiri","year":"2017","journal-title":"J. Dent. Biomater."},{"key":"10.1016\/j.addr.2023.114969_b0370","unstructured":"CLSI, M44 Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, 3rd Edition, in: C.a.L.S. Institute (Ed.), Wayne, Pennsylvania, 2018."},{"key":"10.1016\/j.addr.2023.114969_b0375","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/0973-029X.164534","article-title":"An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar Pradesh","volume":"19","author":"Dar","year":"2015","journal-title":"J. Oral Maxillof. Pathol."},{"key":"10.1016\/j.addr.2023.114969_b0380","unstructured":"R. Diagnostica, Susceptibility Testing of Yeasts 2011, Agar Diffusion Method with Neo-Sensitabs, ROSCO Diagnostica, TaasTrup, Denmark, 2011."},{"key":"10.1016\/j.addr.2023.114969_b0385","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/pathogens10020165","article-title":"The Minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance","volume":"10","author":"Kowalska-Krochmal","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.addr.2023.114969_b0390","first-page":"B4698","article-title":"Candida and candidaemia. Susceptibility and epidemiology","volume":"60","author":"Arendrup","year":"2013","journal-title":"Dan. Med. J."},{"key":"10.1016\/j.addr.2023.114969_b0395","unstructured":"C.f.D.C.a.P. (CDC), Types of Fungal Diseases, Centers for Disease Control and Prevention (CDC), 2023."},{"key":"10.1016\/j.addr.2023.114969_b0400","doi-asserted-by":"crossref","unstructured":"F. Sousa, D. Ferreira, S. Reis, P. Costa, Is Micro and Nanotechnology Helping Us Fight Histoplasmosis?, in: D. Dr. Elena, D. Dr. Elena (Eds.) Histoplasmosis - An Overview, IntechOpen, Rijeka, 2023.","DOI":"10.5772\/intechopen.110544"},{"key":"10.1016\/j.addr.2023.114969_b0405","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ijbiomac.2016.12.065","article-title":"Identification of multi-targeted anti-migraine potential of nystatin and development of its brain targeted chitosan nanoformulation","volume":"96","author":"Girotra","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2023.114969_b0410","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.2174\/1568026619666181220114627","article-title":"Activity of fenticonazole, tioconazole and nystatin on new world Leishmania species","volume":"18","author":"Yamamoto","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.addr.2023.114969_b0415","doi-asserted-by":"crossref","unstructured":"L.F. Gon\u00e7alves-Oliveira, J.F. Peixoto, G. Dias-Lopes, F. Souza-Silva, L.M.d.C. C\u00f4rtes, H.V.A. Rocha, C.R. Alves, Assessing nystatin cream treatment efficacy against Leishmania (L.) amazonensis infection in BALB\/c model, Exp. Parasitol. 250 (2023) 108547.","DOI":"10.1016\/j.exppara.2023.108547"},{"key":"10.1016\/j.addr.2023.114969_b0420","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/aid.1993.9.475","article-title":"Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents","volume":"9","author":"Selvam","year":"1993","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.addr.2023.114969_b0425","first-page":"31854","article-title":"Repurposed nystatin to inhibit SARS-CoV-2 and mutants in the GI tract","volume":"40","author":"Vir\u00e1g","year":"2021","journal-title":"Biomed. J. Sci. Techn. Res."},{"key":"10.1016\/j.addr.2023.114969_b0430","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1021\/acs.jproteome.0c00383","article-title":"In silico drug repurposing for SARS-CoV-2 main proteinase and spike proteins","volume":"19","author":"Maffucci","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.addr.2023.114969_b0435","article-title":"Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor","volume":"26","author":"Ahsan","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.addr.2023.114969_b0440","unstructured":"A. Pharmaceuticals, Clinical Trial NCT00002097: A Phase I\/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection, 2001."},{"key":"10.1016\/j.addr.2023.114969_b0445","unstructured":"A. Pharmaceuticals, Clinical Trial NCT00002313: A Study of Nystatin in HIV-Infected Patients, 2001."},{"key":"10.1016\/j.addr.2023.114969_b0450","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0714.1999.tb02007.x","article-title":"The in vitro post-antifungal effect of nystatin on Candida species of oral origin","volume":"28","author":"Ellepola","year":"1999","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.addr.2023.114969_b0455","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/AAC.44.10.2887-2890.2000","article-title":"In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect","volume":"44","author":"Gunderson","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0460","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1034\/j.1600-0714.2000.290503.x","article-title":"Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates","volume":"29","author":"Egusa","year":"2000","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.addr.2023.114969_b0465","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1034\/j.1600-0714.2001.030008481.x","article-title":"Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease","volume":"30","author":"Anil","year":"2001","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.addr.2023.114969_b0470","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1590\/1678-775720150100","article-title":"Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans","volume":"23","author":"Ellepola","year":"2015","journal-title":"J. Appl. Oral Sci."},{"key":"10.1016\/j.addr.2023.114969_b0475","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/13693780903496583","article-title":"The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata","volume":"48","author":"Samaranayake","year":"2010","journal-title":"Med. Mycol."},{"key":"10.1016\/j.addr.2023.114969_b0480","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/myc.12102","article-title":"The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates","volume":"57","author":"Ellepola","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.addr.2023.114969_b0485","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/17.3.269","article-title":"Suggested mechanisms for the antimycotic activity of the polyene antibiotics and the N-substituted imidazoles","volume":"17","author":"Thomas","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0490","unstructured":"WebMD, Nystatin - Uses, Side Effects, and More, Internet Brands."},{"key":"10.1016\/j.addr.2023.114969_b0495","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s001050050776","article-title":"Akute generalisierte exanthematische Pustulose, induziert durch Nystatin","volume":"49","author":"Rosenberger","year":"1998","journal-title":"Hautarzt"},{"key":"10.1016\/j.addr.2023.114969_b0500","doi-asserted-by":"crossref","unstructured":"D.M. MacCallum, Antifungal agents, in: C.C. Kibbler, R. Barton, N.A.R. Gow, S. Howell, D.M. MacCallum, R.J. Manuel, C.C. Kibbler, R. Barton, N.A.R. Gow, S. Howell, D.M. MacCallum, R.J. Manuel (Eds.) Oxford Textbook of Medical Mycology, Oxford University Press, 2018, pp. 343\u2013349.","DOI":"10.1093\/med\/9780198755388.003.0046"},{"key":"10.1016\/j.addr.2023.114969_b0505","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/toxsci\/53.2.421","article-title":"The reproductive and developmental toxicity of the antifungal drug Nyotran (liposomal nystatin) in rats and rabbits","volume":"53","author":"Larson","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0510","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10611860600720384","article-title":"Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model","volume":"14","author":"Khan","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2023.114969_b0515","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.homp.2004.02.006","article-title":"Anti-inflammatory activity of Arnica montana 6cH: preclinical study in animals","volume":"93","author":"Mac\u00eado","year":"2004","journal-title":"Homeopathy"},{"key":"10.1016\/j.addr.2023.114969_b0520","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ptr.2749","article-title":"Khanum, Anti-inflammatory activity of Rhodiola rosea \u2013 \u201ca second-generation adaptogen\u201d","volume":"23","author":"Pooja","year":"2009","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2023.114969_b0525","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1128\/AAC.49.8.3546-3549.2005","article-title":"Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism","volume":"49","author":"Razonable","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0530","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/jac\/dks117","article-title":"Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice","volume":"67","author":"Semis","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0535","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3390\/molecules21010006","article-title":"Solubilization behavior of polyene antibiotics in nanomicellar system: insights from molecular dynamics simulation of the amphotericin B and nystatin interactions with polysorbate 80","volume":"21","author":"Mobasheri","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2023.114969_b0540","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1128\/AAC.42.8.1878","article-title":"Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins","volume":"42","author":"Cassidy","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0545","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1128\/AAC.45.10.2781-2786.2001","article-title":"Differential antifungal activity of isomeric forms of nystatin","volume":"45","author":"Ostrosky-Zeichner","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0550","unstructured":"M.J. O'Neil, The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals, in: N.M.a.C. Whitehouse Station, Inc. (Ed.), 2001, pp. 1208."},{"key":"10.1016\/j.addr.2023.114969_b0555","first-page":"759","article-title":"Compounded preparations with nystatin for oral and oromucosal administration","volume":"70","author":"Sklenar","year":"2013","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.addr.2023.114969_b0560","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molliq.2016.02.081","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: design, optimization, in vitro and in vivo evaluation","volume":"218","author":"Kassem","year":"2016","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.addr.2023.114969_b0565","doi-asserted-by":"crossref","DOI":"10.1590\/S1984-82502010000200018","article-title":"Development and validation of an HPLC method for stability evaluation of nystatin","volume":"46","author":"Cione","year":"2010","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0570","doi-asserted-by":"crossref","unstructured":"Z.M.M. Lavra, F. S\u00f4nego, R.M.F.d. Silva, F.P.M.d. Medeiros, Desenvolvimento e valida\u00e7\u00e3o de m\u00e9todo anal\u00edtico para nistatina creme vaginal por cromatografia l\u00edquida de alta efici\u00eancia, Revista Brasileira de Ci\u00eancias Farmac\u00eauticas, 44 (2008) 4.","DOI":"10.1590\/S1516-93322008000400010"},{"key":"10.1016\/j.addr.2023.114969_b0575","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jpba.2007.06.014","article-title":"HPLC method for the determination of nystatin in saliva for application in clinical studies","volume":"45","author":"Llabot","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.addr.2023.114969_b0580","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.26452\/ijrps.v10i4.1760","article-title":"Fasten, simple, and specific stability of the avant-garde RP-HPLC method for estimation and validation of nystatin in pharmaceutical formulations","volume":"10","author":"Al-Bahadily","year":"2019","journal-title":"Int. J. Res. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0585","first-page":"43","article-title":"A novel high performance liquid chromatographic method for determination of nystatin in pharmaceutical formulations by Box-Behnken statistical experiment design, Iran","volume":"14","author":"Shokraneh","year":"2015","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.addr.2023.114969_b0590","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/chromsci\/bms127","article-title":"HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin","volume":"50","author":"Heneedak","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0595","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1002\/app.38084","article-title":"Synthesis, characterization, and antifungal activity of nystatin\u2014gum arabic conjugates","volume":"127","author":"Stefanovic","year":"2013","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0600","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.colsurfa.2013.11.010","article-title":"A polysiloxane surfactant dissolves a poorly soluble drug (nystatin) in water","volume":"443","author":"Racles","year":"2014","journal-title":"Colloids Surf. A: Physicochem. Eng. Asp."},{"key":"10.1016\/j.addr.2023.114969_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.supflu.2023.105858","article-title":"Using the supercritical carbon dioxide as the solvent of Nystatin: studying the effect of co-solvent, experimental and correlating","volume":"194","author":"Sajadian","year":"2023","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.addr.2023.114969_b0610","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/13693786.2012.700492","article-title":"The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic","volume":"51","author":"Silva","year":"2013","journal-title":"Med. Mycol."},{"key":"10.1016\/j.addr.2023.114969_b0615","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1096\/fj.13-235440","article-title":"Unexpected low-dose toxicity of the universal solvent DMSO","volume":"28","author":"Galvao","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2023.114969_b0620","first-page":"75","article-title":"Formulation, In-vitro and In-vivo evaluation of Nystatin topical gel","volume":"10","author":"Elosaily","year":"2014","journal-title":"J. Am. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0625","first-page":"592","article-title":"Preparation and evaluation of nystatin loaded-solid-lipid nanoparticles for topical delivery, Madhya Pradesh, India","author":"Samein","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0630","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1002\/jps.23249","article-title":"Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies","volume":"101","author":"Fern\u00e1ndez-Campos","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0635","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1439-0507.2012.02202.x","article-title":"Evaluation of novel nystatin nanoemulsion for skin candidosis infections","volume":"56","author":"Fernandez-Campos","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.addr.2023.114969_b0640","first-page":"1671","article-title":"Formulation, characterization and in vitro evaluation of antifungal activity of Nystatin micro emulsion for topical application","volume":"32","author":"Maqsood","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0645","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3109\/03639049009023636","article-title":"Chewing gum as a drug delivery system for nystatin influence of solubilising agents upon the release of water insoluble drugs","volume":"16","author":"Andersen","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2023.114969_b0650","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.dental.2006.08.005","article-title":"Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer","volume":"23","author":"Tallury","year":"2007","journal-title":"Dent. Mater."},{"key":"10.1016\/j.addr.2023.114969_b0655","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2003.11.003","article-title":"The effects of Pluronic block copolymers on the aggregation state of nystatin","volume":"95","author":"Croy","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114969_b0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2013.01.005","article-title":"Novel microparticulate systems for the vaginal delivery of nystatin: development and characterization","volume":"94","author":"Martin-Villena","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2023.114969_b0665","doi-asserted-by":"crossref","DOI":"10.1088\/1748-3190\/aad488","article-title":"Mucoadhesive assessment of different antifungal nanoformulations","volume":"13","author":"Roque","year":"2018","journal-title":"Bioinspir. Biomim."},{"key":"10.1016\/j.addr.2023.114969_b0670","first-page":"2292","article-title":"Preparation and characterization of nystatin-loaded solid lipid nanoparticles for topical delivery","volume":"4","author":"Khalil","year":"2010","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.addr.2023.114969_b0675","unstructured":"R.M. Khalil, A.A.A.E. Rahman, M.A. Kassem, M.S.E. Ridi, M.M.A. Samra, G.E.A. Awad, S.S. Mansy, Preparation and in vivo assessment of nystatin-loaded solid lipid nanoparticles for topical delivery against Cutaneous Candidiasis, (2014) 401\u2013409."},{"key":"10.1016\/j.addr.2023.114969_b0680","first-page":"490","article-title":"Formulation and characterization of nystatin-loaded nanostructured lipid carriers for topical delivery against Cutaneous Candidiasis","volume":"4","author":"Khalil","year":"2013","journal-title":"J. Pharm. Res. Int."},{"key":"10.1016\/j.addr.2023.114969_b0685","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.crci.2014.09.012","article-title":"Influence of basil oil extract on the antioxidant and antifungal activities of nanostructured carriers loaded with nystatin","volume":"18","author":"Badea","year":"2015","journal-title":"C. R. Chim."},{"key":"10.1016\/j.addr.2023.114969_b0690","doi-asserted-by":"crossref","first-page":"224","DOI":"10.26650\/IstanbulJPharm.2020.0006","article-title":"Development of inhalable cubosome nanoparticles of Nystatin for effective management of Invasive Pulmonary Aspergillosis","volume":"50","author":"Kazi","year":"2020","journal-title":"J. Pharm. Istanbul Univ."},{"key":"10.1016\/j.addr.2023.114969_b0695","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3109\/03639045.2011.587431","article-title":"Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin","volume":"37","author":"El-Ridy","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2023.114969_b0700","first-page":"224","article-title":"Development and evaluation of antifungal topical niosomal gel formulation, International","volume":"3","author":"Desai","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112304","article-title":"Design of transfersomal nanocarriers of nystatin for combating vulvovaginal candidiasis; a different prospective","volume":"211","author":"Hady","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2023.114969_b0710","first-page":"1","article-title":"Formulation and evaluation of nystatin microparticles as a sustained release system, Iraqi","volume":"24","author":"Alkotaji","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0715","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.carbpol.2014.09.032","article-title":"Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery","volume":"117","author":"Mart\u00edn","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2023.114969_b0720","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/10837450.2014.999783","article-title":"Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment","volume":"21","author":"Pinto Reis","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.addr.2023.114969_b0725","doi-asserted-by":"crossref","first-page":"12984","DOI":"10.1038\/s41598-020-70085-z","article-title":"Terpinen-4-ol and nystatin co-loaded precursor of liquid crystalline system for topical treatment of oral candidiasis","volume":"10","author":"Francisconi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.114969_b0730","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1002\/jps.23711","article-title":"Formulation design and optimization for the improvement of nystatin-loaded lipid intravenous emulsion","volume":"102","author":"Mar\u00edn-Quintero","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b0735","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/1539445X.2010.495627","article-title":"Siloxane-based surfactants containing tromethamol units","volume":"8","author":"Racles","year":"2010","journal-title":"Soft Mater."},{"key":"10.1016\/j.addr.2023.114969_b0740","first-page":"5","article-title":"Polyurethane-hydroxypropyl cellulose membranes for sustained release of nystatin","volume":"47","author":"M\u00e2ndru","year":"2013","journal-title":"Cellul. Chem. Technol."},{"key":"10.1016\/j.addr.2023.114969_b0745","article-title":"Sustained release of nystatin from polyurethane membranes for biomedical applications","volume":"6","author":"Mihaela","year":"2011","journal-title":"Dig. J. Nanomater. Biostruct."},{"key":"10.1016\/j.addr.2023.114969_b0750","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/(SICI)1099-0518(199605)34:7<1229::AID-POLA9>3.0.CO;2-Y","article-title":"Nystatin\u2014dextran conjugates: synthesis and characterization","volume":"34","author":"Domb","year":"1996","journal-title":"J. Polym. Sci. A Polym. Chem."},{"key":"10.1016\/j.addr.2023.114969_b0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.10.034","article-title":"Targeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate","volume":"386","author":"B\u00edlkov\u00e1","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.114969_b0760","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10847-012-0281-y","article-title":"Gamma-cyclodextrin on enhancement of water solubility and store stability of nystatin","volume":"78","author":"Wang","year":"2014","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.addr.2023.114969_b0765","doi-asserted-by":"crossref","unstructured":"R.S.d.S. Moreira, J.S. Novais, R.F.d. Silva, R.P. Nunes, L.C.L.d. Abreu, E.P. Dias, H.C. Castro, F.A.d. Carmo, C.R. Rodrigues, V.P.d. Sousa, L.M. Cabral, Preparation and evaluation of red propolis and nystatin cyclodextrin inclusion complexes against oral microbiome opportunistic microorganisms, Food Sci. Technol. 42 (2022) 118022.","DOI":"10.1590\/fst.118022"},{"key":"10.1016\/j.addr.2023.114969_b0770","doi-asserted-by":"crossref","unstructured":"I. Kadota, Y. Hu, G.K. Packard, S.D. Rychnovsky, A unified approach to polyene macrolides: Synthesis of candidin and nystatin polyols, Proc. Natl. Acad. Sci. 101 (2004) 11992\u201311995.","DOI":"10.1073\/pnas.0401552101"},{"key":"10.1016\/j.addr.2023.114969_b0775","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1074-5521(00)00120-4","article-title":"Biosynthesis of the polyene antifungal antibiotic nystatin in Streptomyces noursei ATCC 11455: analysis of the gene cluster and deduction of the biosynthetic pathway","volume":"7","author":"Brautaset","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.addr.2023.114969_b0780","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.chembiol.2008.08.009","article-title":"Improved antifungal polyene macrolides via engineering of the nystatin biosynthetic genes in Streptomyces noursei","volume":"15","author":"Brautaset","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.addr.2023.114969_b0785","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1074-5521(02)00108-4","article-title":"Hexaene derivatives of nystatin produced as a result of an induced rearrangement within the nysC polyketide synthase gene in S. noursei ATCC 11455","volume":"9","author":"Brautaset","year":"2002","journal-title":"Chem. Biol."},{"key":"10.1016\/j.addr.2023.114969_b0790","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1128\/AAC.48.11.4120-4129.2004","article-title":"Chemical diversity of polyene macrolides produced by Streptomyces noursei ATCC 11455 and recombinant strain ERD44 with genetically altered polyketide synthase NysC","volume":"48","author":"Bruheim","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0795","first-page":"18","article-title":"Comparative analysis of in vitro antifungal activity and in vivo acute toxicity of the nystatin analogue S44HP produced via genetic engineering","volume":"50","author":"Treshchalin","year":"2005","journal-title":"Antibiot. Khimioter."},{"key":"10.1016\/j.addr.2023.114969_b0800","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1021\/jm050895w","article-title":"Probing the structure\u2212function relationship of polyene macrolides: engineered biosynthesis of soluble nystatin analogues","volume":"49","author":"Borgos","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2023.114969_b0805","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1128\/AEM.01122-07","article-title":"Analysis of the mycosamine biosynthesis and attachment genes in the nystatin biosynthetic gene cluster of Streptomyces noursei ATCC 11455","volume":"73","author":"Nedal","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b0810","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1128\/AAC.00270-13","article-title":"Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group","volume":"57","author":"Tevyashova","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0815","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1128\/AEM.05780-11","article-title":"New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei","volume":"77","author":"Brautaset","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b0820","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1021\/jm800695k","article-title":"Chemical modification and biological evaluation of new semisynthetic derivatives of 28,29-didehydronystatin A1 (S44HP), a genetically engineered antifungal polyene macrolide antibiotic","volume":"52","author":"Preobrazhenskaya","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2023.114969_b0825","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ja.2009.118","article-title":"Synthesis and study of the antifungal activity of new mono- and disubstituted derivatives of a genetically engineered polyene antibiotic 28,29-didehydronystatin A1 (S44HP)","volume":"63","author":"Preobrazhenskaya","year":"2010","journal-title":"J. Antibiot."},{"key":"10.1016\/j.addr.2023.114969_b0830","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00253-012-3955-x","article-title":"Structural analysis and biosynthetic engineering of a solubility-improved and less-hemolytic nystatin-like polyene in Pseudonocardia autotrophica","volume":"95","author":"Lee","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.addr.2023.114969_b0835","doi-asserted-by":"crossref","first-page":"13584","DOI":"10.1038\/s41598-018-31801-y","article-title":"Nystatin-like Pseudonocardia polyene B1, a novel disaccharide-containing antifungal heptaene antibiotic","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.114969_b0840","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00430-014-0343-4","article-title":"Novel Nystatin A1 derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis","volume":"203","author":"Boros-Majewska","year":"2014","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2023.114969_b0845","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/antibiotics12010151","article-title":"Semisynthetic amides of amphotericin B and nystatin A1: a comparative study of in vitro activity\/toxicity ratio in relation to selectivity to ergosterol membranes","volume":"12","author":"Tevyashova","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.addr.2023.114969_b0850","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0168-3659(95)00158-1","article-title":"Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport","volume":"39","author":"Colombo","year":"1996","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114969_b0855","unstructured":"A.S. Biosergen, L. Select Pharma Pty, C. Greenlight, L. Nucleus network, clinical trial NCT04921254: a study to assess the safety, tolerability and pharmacokinetics of BSG005, 2023."},{"key":"10.1016\/j.addr.2023.114969_b0860","article-title":"Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis","volume":"30","author":"Jafri","year":"2020","journal-title":"J. Mycol. M\u00e9dicale"},{"key":"10.1016\/j.addr.2023.114969_b0865","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25259\/GJMPBU_18_2022","article-title":"Antifungal effects of thymol-loaded chitosan nanocomposite alone and in combined with nystatin against Candida albicans, a major cause of oral Candidiasis","volume":"17","author":"Azadbakht","year":"2022","journal-title":"Glob. J. Med. Pharm. Biomed. Update"},{"key":"10.1016\/j.addr.2023.114969_b0870","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12906-015-0947-2","article-title":"Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study","volume":"15","author":"de Castro","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.addr.2023.114969_b0875","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.phymed.2009.02.011","article-title":"In vitro synergic efficacy of the combination of Nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species","volume":"16","author":"Rosato","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2023.114969_b0880","first-page":"666","article-title":"In vitro evaluation of antimicrobial activity of combinations of nystatin and Euphorbia hirta leaf extract against Candida albicans by the Checkerboard Method","volume":"3","author":"Jackson","year":"2009","journal-title":"J. Med. Plant Res."},{"key":"10.1016\/j.addr.2023.114969_b0885","doi-asserted-by":"crossref","unstructured":"I.G.d. Silva, H.B.d.P. Santos, Y.W. Cavalcanti, C.F.W. Nonaka, S.A.d. Sousa, R.D.d. Castro, Antifungal Activity of Eugenol and its Association with Nystatin on Candida albicans, Pesquisa Brasileira em Odontopediatria e Cl\u00ednica Integrada, 17 (2017) 3235.","DOI":"10.4034\/PBOCI.2017.171.16"},{"key":"10.1016\/j.addr.2023.114969_b0890","first-page":"81","article-title":"Antimicrobial, antioxidant, and synergistic properties of two nutraceutical plants: Terminalia catappa L. and Colocasia esculenta L","volume":"37","author":"Baravalia","year":"2013","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.addr.2023.114969_b0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112518","article-title":"Alginate oligosaccharides inhibit fungal cell growth and potentiate the activity of antifungals against Candida and Aspergillus spp.","volume":"9","author":"T\u00f8ndervik","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2023.114969_b0900","doi-asserted-by":"crossref","unstructured":"N. P\u00e9rez-Gonz\u00e1lez, M.J. Mart\u00edn-Villena, A.C. Calpena-Campmany, J.A. Morales-Molina, B. Clares-Naveros, Novel Strategy for the Formulation of Poorly Water-Soluble Drugs: Nystatin Microencapsulation, Proceedings, 78 (2021) 41.","DOI":"10.3390\/IECP2020-08898"},{"key":"10.1016\/j.addr.2023.114969_b0905","doi-asserted-by":"crossref","first-page":"540","DOI":"10.34172\/jhp.2022.62","article-title":"Antifungal effects of zinc nanoparticles green synthesized by Lavandula angustifolia extract, alone and combined with nystatin against Candida albicans, a major cause of oral candidiasis","volume":"11","author":"Nasiri","year":"2022","journal-title":"J. Herbmed. Pharmacol."},{"key":"10.1016\/j.addr.2023.114969_b0910","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/AAC.31.12.1901","article-title":"Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections","volume":"31","author":"Mehta","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0915","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1128\/AAC.41.10.2238","article-title":"Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice","volume":"41","author":"Wallace","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0920","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/43.1.95","article-title":"Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics","volume":"43","author":"Groll","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0925","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-5173(99)00222-7","article-title":"Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives","volume":"188","author":"Moribe","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.114969_b0930","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/1061186031000119093","article-title":"Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B","volume":"11","author":"Khan","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2023.114969_b0935","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1574-695X.2012.00992.x","article-title":"Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB\/C mice","volume":"66","author":"Khan","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b0940","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dki454","article-title":"Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model","volume":"57","author":"Nasti","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0945","doi-asserted-by":"crossref","first-page":"44","DOI":"10.18869\/acadpub.pbr.2.1.44","article-title":"Encapsulation of nystatin in nanoliposomal formulation: characterization, stability study and antifungal activity against Candida albicans","volume":"2","author":"Saadat","year":"2016","journal-title":"Pharm. Biomed. Res."},{"key":"10.1016\/j.addr.2023.114969_b0950","unstructured":"R.M.G. Vankadari, N. Devanna, D.S. K, Ethanolic vesicles of nystatin for enhanced transdermal drug delivery: in vitro and ex vivo evaluation, Indo Am. J. Pharm. Res. 3 (2013) 7316\u20137324."},{"key":"10.1016\/j.addr.2023.114969_b0955","doi-asserted-by":"crossref","first-page":"22110","DOI":"10.1038\/s41598-022-26523-1","article-title":"Preparation, characterization and properties of three different nanomaterials either alone or loaded with nystatin or fluconazole antifungals","volume":"12","author":"Helal","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.114969_b0960","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11046-009-9271-z","article-title":"Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds","volume":"169","author":"Semis","year":"2010","journal-title":"Mycopathologia"},{"key":"10.1016\/j.addr.2023.114969_b0965","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijantimicag.2011.04.018","article-title":"Activity of an Intralipid formulation of nystatin in murine systemic candidiasis","volume":"38","author":"Semis","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2023.114969_b0970","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/13693786.2012.731712","article-title":"Mechanism of activity and toxicity of Nystatin-Intralipid","volume":"51","author":"Semis","year":"2013","journal-title":"Med. Mycol."},{"key":"10.1016\/j.addr.2023.114969_b0975","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mycmed.2014.12.002","article-title":"Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods","volume":"25","author":"Semis","year":"2015","journal-title":"J Mycol Med"},{"key":"10.1016\/j.addr.2023.114969_b0980","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/jac\/dkt137","article-title":"Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans","volume":"68","author":"Melkoumov","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2023.114969_b0985","doi-asserted-by":"crossref","first-page":"34","DOI":"10.31083\/2019.8138","article-title":"Nystatin antifungal micellar systems on endotracheal tubes: development, characterization and in vitro evaluation","volume":"74","author":"Benavent","year":"2019","journal-title":"Pharmazie"},{"key":"10.1016\/j.addr.2023.114969_b0990","first-page":"1","article-title":"Nasal mucoadhesive in situ gelling liquid crystalline fluid precursor system of polyene antibiotic for potential treatment of localized sinuses aspergillosis post COVID infection","author":"Kazi-Chishti","year":"2023","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.addr.2023.114969_b0995","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2478\/afpuc-2020-0009","article-title":"Preparation and evaluation of an oral mucoadhesive gel containing nystatin-loaded alginate microparticles","volume":"67","author":"Mohammadi Samani","year":"2020","journal-title":"Eur. Pharm. J."},{"key":"10.1016\/j.addr.2023.114969_b1000","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1166\/jnn.2018.14866","article-title":"Antifungal effect of a dental tissue conditioner containing nystatin-loaded alginate microparticles","volume":"18","author":"Kim","year":"2018","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.addr.2023.114969_b1005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/1567201813666160513132456","article-title":"Dextran based polymeric micelles as carriers for delivery of hydrophobic drugs","volume":"14","author":"Mocanu","year":"2017","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.addr.2023.114969_b1010","first-page":"736","article-title":"Dendrimers: potential tool for enhancement of antifungal activity","volume":"2","author":"Khairnar","year":"2010","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.addr.2023.114969_b1015","unstructured":"K.E.C. Kanchana, Formulation, Characterization and Evaluation of Nanosponge Gel for the Treatment of Candidiasis, College of Pharmacy, Madras Medical College, Chennai, 2016, pp. 124."},{"key":"10.1016\/j.addr.2023.114969_b1020","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2174\/138527212803520173","article-title":"Novel melatonin-chitosan hydrogels as suitable oral bio-drug delivery systems to fight oral mucositis: synergy of antioxidants and bioactives in action","volume":"16","author":"Perchyonok","year":"2012","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.addr.2023.114969_b1025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/jfb5040259","article-title":"Evaluation of nystatin containing chitosan hydrogels as potential dual action bio-active restorative materials: in vitro approach","volume":"5","author":"Perchyonok","year":"2014","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.addr.2023.114969_b1030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4103\/1305-7456.120666","article-title":"Insights into and relative effect of chitosan-H, chitosan-H-propolis, chitosan-H-propolis-nystatin and chitosan-H-nystatin on dentine bond strength","volume":"7","author":"Perchyonok","year":"2013","journal-title":"Eur. J. Dent."},{"key":"10.1016\/j.addr.2023.114969_b1035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/gels8080495","article-title":"Evaluation of physically and\/or chemically modified chitosan hydrogels for proficient release of insoluble nystatin in simulated fluids","volume":"8","author":"Enache","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.addr.2023.114969_b1040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijbiomac.2022.01.031","article-title":"Multilayered mucoadhesive hydrogel films based on Ocimum basilicum seed mucilage\/thiolated alginate\/dopamine-modified hyaluronic acid and PDA coating for sublingual administration of nystatin","volume":"203","author":"Sadat Hosseini","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2023.114969_b1045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.07.018","article-title":"Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: development and characterization","volume":"96","author":"Bassi","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2023.114969_b1050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.25130\/tjps.v23i7.698","article-title":"Synthesis, characterization and antifungal activity of coated silver nanoparticles-nystatin and coated silver nanoparticles-clotrimazol","volume":"23","author":"Hameed","year":"2018","journal-title":"Tikrit J. Pure Sci."},{"key":"10.1016\/j.addr.2023.114969_b1055","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/myc.12093","article-title":"Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms","volume":"56","author":"Monteiro","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.addr.2023.114969_b1060","doi-asserted-by":"crossref","unstructured":"A. Ayaz, lt, sup, gt, lt, sup, gt, S. Ruqaiyyah, lt, sup, gt, lt, sup, gt, S. Muhammad, lt, sup, gt, lt, sup, gt, K. Naveed, lt, sup, gt, *, lt, sup, gt, Gold Nanoparticles Conjugation Enhances Antiacanthamoebic Properties of Nystatin, Fluconazole and Amphotericin B, J. Microbiol. Biotechnol. 29 (2019) 171\u2013177.","DOI":"10.4014\/jmb.1805.05028"},{"key":"10.1016\/j.addr.2023.114969_b1065","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.nano.2016.07.006","article-title":"Magnetic nanoparticles as a drug delivery system that enhance fungicidal activity of polyene antibiotics","volume":"12","author":"Niemirowicz","year":"2016","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2023.114969_b1070","first-page":"1","article-title":"Design and in vitro antifungal activity of Nystatin loaded chitosan-coated magnetite nanoparticles for targeted therapy","author":"Zomorodian","year":"2021","journal-title":"Inorg. Nano-Metal Chem."},{"key":"10.1016\/j.addr.2023.114969_b1075","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/651831","article-title":"Antimicrobial and controlled release studies of a novel nystatin conjugated iron oxide nanocomposite","volume":"2014","author":"Hussein-Al-Ali","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.addr.2023.114969_b1080","doi-asserted-by":"crossref","first-page":"9274","DOI":"10.1039\/C9RA10765G","article-title":"Nystatin-mediated bismuth oxide nano-drug synthesis using gamma rays for increasing the antimicrobial and antibiofilm activities against some pathogenic bacteria and Candida species","volume":"10","author":"El-Batal","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.addr.2023.114969_b1085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/2231-4040.82950","article-title":"Nanosuspension: an approach to enhance solubility of drugs","volume":"2","author":"Patel","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.addr.2023.114969_b1090","first-page":"397","article-title":"Development of a solid dispersion of nystatin with maltodextrin as a carrier agent: improvements in antifungal efficacy against Candida spp","volume":"14","author":"Benavent","year":"2021","journal-title":"Biofilm Infect. Pharm. (Basel)"},{"key":"10.1016\/j.addr.2023.114969_b1095","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s12272-010-1109-1","article-title":"Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation","volume":"33","author":"Sakeer","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.addr.2023.114969_b1100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5530\/ijper.50.3.10","article-title":"Surface Modification of carbon nano tubes with nystatin for drug delivery applications","volume":"50","author":"Uttekar","year":"2016","journal-title":"Ind. J. Pharm. Educ. Res."},{"key":"10.1016\/j.addr.2023.114969_b1105","unstructured":"D.W. Lee, J.W. Seo, Preparation of carbon nanotubes from graphite powder at room temperature, 2010, pp. arXiv:1007.1062."},{"key":"10.1016\/j.addr.2023.114969_b1110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejps.2013.03.006","article-title":"Technological and biopharmaceutical optimization of nystatin release from a multiparticulate based bioadhesive drug delivery system","volume":"49","author":"P\u00e1l","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b1115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/ph13090248","article-title":"Current insights on antifungal therapy: novel nanotechnology approaches for drug delivery systems and new drugs from natural sources","volume":"13","author":"Sousa","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.addr.2023.114969_b1120","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/03639040903384729","article-title":"Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination","volume":"36","author":"de Aguiar","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2023.114969_b1125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/2230-973X.176487","article-title":"Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasis","volume":"6","author":"Mishra","year":"2016","journal-title":"Int. J. Pharm. Invest."},{"key":"10.1016\/j.addr.2023.114969_b1130","first-page":"585","article-title":"Preparation and characterisation of fluconazole vaginal films for the treatment of vaginal candidiasis","volume":"75","author":"Kumar","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b1135","doi-asserted-by":"crossref","unstructured":"C.d.C. Spadari, L.B. Lopes, K. Ishida, Potential use of alginate-based carriers as antifungal delivery system, Front. Microbiol. 8 (2017) 97.","DOI":"10.3389\/fmicb.2017.00097"},{"key":"10.1016\/j.addr.2023.114969_b1140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/wnan.1181","article-title":"Dendrimers\u2014revolutionary drugs for infectious diseases","volume":"4","author":"Lazniewska","year":"2012","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2023.114969_b1145","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/chemistry4030070","article-title":"Fabrication of polymersomes: a macromolecular architecture in nanotherapeutics","volume":"4","author":"Pallavi","year":"2022","journal-title":"Chemistry"},{"key":"10.1016\/j.addr.2023.114969_b1150","doi-asserted-by":"crossref","unstructured":"S.Q. Qaiser M., Hamza M. and Hussain S., Antifungal drugs loaded nanosponges to improve bioavailability of antifungal drugs; a review, Open Access J. Pharm. Res. 5 (2021) 000255.","DOI":"10.23880\/oajpr-16000255"},{"key":"10.1016\/j.addr.2023.114969_b1155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114969_b1160","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4155\/tde.13.120","article-title":"pH-sensitive drug-delivery systems for tumor targeting","volume":"4","author":"He","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2023.114969_b1165","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.3390\/molecules25235649","article-title":"pH-sensitive biomaterials for drug delivery","volume":"25","author":"Zhuo","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2023.114969_b1170","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.3390\/polym13183154","article-title":", Tuning the properties of PNIPAm-based hydrogel scaffolds for cartilage tissue engineering","volume":"13","author":"Rana","year":"2021","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.addr.2023.114969_b1175","first-page":"61","article-title":"Formulation and characterization of nystatin gel","volume":"27","author":"Qui\u00f1ones","year":"2008","journal-title":"P. R. Health Sci. J."},{"key":"10.1016\/j.addr.2023.114969_b1180","first-page":"116","article-title":"Design and evaluation of nystatin emulgel for superficial skin infection","volume":"10","author":"Sohan","year":"2020","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"10.1016\/j.addr.2023.114969_b1185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/pharmaceutics14010170","article-title":"Evaluation of the mucoadhesive properties of chitosan-based microstructured lipid carrier (CH-MLC)","volume":"14","author":"Guerini","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2023.114969_b1190","unstructured":"Annual Interim Report 2020 10-K405 SEC, Aronex Pharmaceuticals Inc, 2000."},{"key":"10.1016\/j.addr.2023.114969_b1195","first-page":"488","article-title":"Nystatin LF (Aronex\/Abbott)","volume":"2","author":"Arikan","year":"2001","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.addr.2023.114969_b1200","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/AAC.43.11.2592","article-title":"Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B","volume":"43","author":"Denning","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114969_b1205","unstructured":"Nystatin, in: J.K. Aronson (Ed.) Meyler's Side Effects of Drugs (Sixteenth Edition) - The International Encyclopedia of Adverse Drug Reactions and Interactions, Elsevier, Oxford, 2016, pp. 287."},{"key":"10.1016\/j.addr.2023.114969_b1210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.addr.2023.114969_b1215","first-page":"55","article-title":"Ultradeformable phospholipid vesicles as a drug delivery system: a review","author":"Romero","year":"2015","journal-title":"Res. Rep. Transd. Drug Deliv."},{"key":"10.1016\/j.addr.2023.114969_b1220","first-page":"31","article-title":"Niosome-loaded antifungal drugs as an effective nanocarrier system: a mini review","volume":"4","author":"Osanloo","year":"2018","journal-title":"Curr. Med. Mycol."},{"key":"10.1016\/j.addr.2023.114969_b1225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s43094-020-00117-y","article-title":"Recent advances of non-ionic surfactant-based nano-vesicles (niosomes and proniosomes): a brief review of these in enhancing transdermal delivery of drug","volume":"6","author":"Bhavani","year":"2020","journal-title":"Fut. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b1230","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3390\/pharmaceutics13070977","article-title":"Development and optimization of luliconazole spanlastics to augment the antifungal activity against Candida albicans","volume":"13","author":"Alhakamy","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2023.114969_b1235","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.2147\/IJN.S250960","article-title":"Formulation and characterization of sertaconazole nitrate mucoadhesive liposomes for vaginal Candidiasis","volume":"15","author":"Abdellatif","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.114969_b1240","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2147\/JMDH.S359282","article-title":"Review on nanomaterials and nano-scaled systems for topical and systemic delivery of antifungal drugs","volume":"15","author":"Nagasa","year":"2022","journal-title":"J. Multidiscip. Healthc."},{"key":"10.1016\/j.addr.2023.114969_b1245","article-title":"Invasive fungal diseases during COVID-19: We should be prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J. Mycol. M\u00e9dicale"},{"key":"10.1016\/j.addr.2023.114969_b1250","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/amhs.amhs_218_21","article-title":"Dual invasive fungal infection by Aspergillus and mucor in COVID-19 patient: a rare case report with literature review","volume":"9","author":"Rai","year":"2021","journal-title":"Arch. Med. Health Sci."},{"key":"10.1016\/j.addr.2023.114969_b1255","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12070-022-03367-9","article-title":"COVID associated invasive Aspergillosis","volume":"75","author":"Bhandari","year":"2023","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.addr.2023.114969_b1260","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s12070-022-03073-6","article-title":"Invasive Aspergillosis of nose and paranasal sinus in COVID-19 convalescents: mold goes viral?","volume":"74","author":"Shetty","year":"2022","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.addr.2023.114969_b1265","first-page":"33","article-title":"Intranasal nystatin therapy in patients with chronic illness associated with mold and mycotoxins","volume":"15","author":"Brewer","year":"2015","journal-title":"Glob. J. Med. Res."},{"key":"10.1016\/j.addr.2023.114969_b1270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.33380\/2305-2066-2021-10-4-54-63","article-title":"In situ intranasal delivery systems: application prospects and main pharmaceutical aspects of development","volume":"10","author":"Bakhrushina","year":"2021","journal-title":"Drug Dev. Regist."},{"key":"10.1016\/j.addr.2023.114969_b1275","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4155\/tde-2016-0040","article-title":"Solid lipid nanoparticles for antifungal drugs delivery for topical applications","volume":"7","author":"Trombino","year":"2016","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2023.114969_b1280","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1211\/0022357044959","article-title":"Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs","volume":"56","author":"Hu","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2023.114969_b1285","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/02652040600612439","article-title":"Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC","volume":"23","author":"Souto","year":"2006","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.addr.2023.114969_b1290","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.580118","article-title":"Lipid nanoparticles as carriers for bioactive delivery","volume":"9","author":"Dhiman","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2023.114969_b1295","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3390\/nano12132224","article-title":"A versatile nanocarrier \u2013 cubosomes, characterization, and applications","volume":"12","author":"Oliveira","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.addr.2023.114969_b1300","first-page":"104","article-title":"A review on: cubosomes drug delivery system","volume":"5","author":"Karthikeyan","year":"2017","journal-title":"Indian J. Drugs"},{"key":"10.1016\/j.addr.2023.114969_b1305","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.1021\/acs.jafc.8b03210","article-title":"Zinc oxide nanoparticle as a novel class of antifungal agents: current advances and future perspectives","volume":"66","author":"Sun","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.addr.2023.114969_b1310","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3390\/coatings12121864","article-title":"Antifungal properties of zinc oxide nanoparticles on Candida albicans","volume":"12","author":"Djearamane","year":"2022","journal-title":"Coatings"},{"key":"10.1016\/j.addr.2023.114969_b1315","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.17576\/jsm-2022-5105-07","article-title":"Sensitivity of Proteus vulgaris to zinc oxide nanoparticles","volume":"51","author":"Djearamane","year":"2022","journal-title":"Sains Malaysiana"},{"key":"10.1016\/j.addr.2023.114969_b1320","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0036-46652015000200011","article-title":"Antifungal activity of silver nanoparticles obtained by green synthesis","volume":"57","author":"Mallmann","year":"2015","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.addr.2023.114969_b1325","article-title":"Mycogenic fabrication of silver nanoparticles using Picoa, Pezizales, characterization and their antifungal activity","volume":"17","author":"Owaid","year":"2022","journal-title":"Environ. Nanotechnol. Monit. Manage."},{"key":"10.1016\/j.addr.2023.114969_b1330","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.colsurfb.2012.06.005","article-title":"Size and shape dependant antifungal activity of gold nanoparticles: a case study of Candida","volume":"101","author":"Wani","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2023.114969_b1335","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.materresbull.2012.09.069","article-title":"Antifungal activity of gold nanoparticles prepared by solvothermal method","volume":"48","author":"Ahmad","year":"2013","journal-title":"Mater. Res. Bull."},{"key":"10.1016\/j.addr.2023.114969_b1340","doi-asserted-by":"crossref","unstructured":"N. M, S. D, S. Hans, A. Varghese, Z. Fatima, S. Hameed, Studies on the antifungal activity of biotemplated gold nanoparticles over Candida albicans, Mater. Res. Bull. 119 (2019) 110563.","DOI":"10.1016\/j.materresbull.2019.110563"},{"key":"10.1016\/j.addr.2023.114969_b1345","doi-asserted-by":"crossref","first-page":"28092","DOI":"10.1039\/C7RA00720E","article-title":"Unique properties of silver and copper silica-based nanocomposites as antimicrobial agents","volume":"7","author":"Peszke","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.addr.2023.114969_b1350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2019.120850","article-title":"Aqueous-phase synthesis of nanoparticles of copper\/copper oxides and their antifungal effect against Fusarium oxysporum","volume":"380","author":"Hermida-Montero","year":"2019","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.addr.2023.114969_b1355","first-page":"279","article-title":"Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics, 3","volume":"8","author":"Vallabani","year":"2018","journal-title":"Biotech"},{"key":"10.1016\/j.addr.2023.114969_b1360","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.micpath.2017.12.068","article-title":"Preparation, characterization and antifungal activity of iron oxide nanoparticles","volume":"115","author":"Parveen","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.addr.2023.114969_b1365","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/ijms17091534","article-title":"Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches","volume":"17","author":"Zhang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2023.114969_b1370","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114969_b1375","first-page":"592","article-title":"Advances in biogenic nanoparticles and the mechanisms of antimicrobial effects","volume":"80","author":"Qidway","year":"2018","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.addr.2023.114969_b1380","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.archoralbio.2018.02.009","article-title":"Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans","volume":"89","author":"Scheibler","year":"2018","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.addr.2023.114969_b1385","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.3390\/ijms221810104","article-title":"Striking back against fungal infections: the utilization of nanosystems for antifungal strategies","volume":"22","author":"Du","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2023.114969_b1390","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","article-title":"Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs","volume":"12","author":"Vasconcelos","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2023.114969_b1395","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.addr.2023.114969_b1400","doi-asserted-by":"crossref","unstructured":"V. Jhawat, M. Gulia, A.K. Sharma, Chapter 15 - Pseudoternary phase diagrams used in emulsion preparation, in: N. Sharma, H. Ojha, P.K. Raghav, R.K. Goyal (Eds.) Chemoinformatics and Bioinformatics in the Pharmaceutical Sciences, Academic Press, 2021, pp. 455\u2013481.","DOI":"10.1016\/B978-0-12-821748-1.00011-7"},{"key":"10.1016\/j.addr.2023.114969_b1405","doi-asserted-by":"crossref","unstructured":"S. Beg, S. Akhter, Box\u2013Behnken Designs and Their Applications in Pharmaceutical Product Development, 2021, pp. 77-85.","DOI":"10.1007\/978-981-33-4717-5_7"},{"key":"10.1016\/j.addr.2023.114969_b1410","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/10837450.2014.908300","article-title":"Application of quality by design (QbD) to formulation and processing of naproxen pellets by extrusion-spheronization","volume":"20","author":"Wang","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.addr.2023.114969_b1415","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1142029","article-title":"Progress of polymer-based strategies in fungal disease management: designed for different roles","volume":"13","author":"Wu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b1420","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/acs.biomac.6b01704","article-title":"Stimuli-responsive polymersomes for biomedical applications","volume":"18","author":"Hu","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2023.114969_b1425","first-page":"2237","article-title":"Treatment of oral candidiasis: a study to determine the clinical response of sodium benzoate compared with nystatin suspension","volume":"12","author":"Moshi","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2023.114969_b1430","unstructured":"Nystatin and Triamcinolone Acetonide, in: J.P. Cunha (Ed.), RxList, 2023."},{"key":"10.1016\/j.addr.2023.114969_b1435","unstructured":"Nystatin Oral Suspension, RxList, 2023."},{"key":"10.1016\/j.addr.2023.114969_b1440","unstructured":"Nystatin - Drug Summary, PDR Prescribers\u2019 Digital Reference, 2023."},{"key":"10.1016\/j.addr.2023.114969_b1445","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/jama.1969.03160210023006","article-title":"Primary disseminated pulmonary Aspergillosis with metastatic skin nodules: successful treatment with inhalation nystatin therapy","volume":"209","author":"Vedder","year":"1969","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.addr.2023.114969_b1450","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1378\/chest.51.1.96","article-title":"Allergic pulmonary aspergillosis successfully treated with inhalations of nystatin. Report of a case","volume":"51","author":"Stark","year":"1967","journal-title":"Dis. Chest"},{"key":"10.1016\/j.addr.2023.114969_b1455","first-page":"158","article-title":"Acute pulmonary aspergillosis caused by Aspergillus fumigatus and successful treatment with nystatin","volume":"8","author":"Gemeinhardt","year":"1965","journal-title":"Mykosen"},{"key":"10.1016\/j.addr.2023.114969_b1460","first-page":"369","article-title":"Acute lung aspergillosis and successful treatment with Nystatin","volume":"124","author":"Sch\u00fcttmann","year":"1965","journal-title":"Z. Tuberk. Erkr. Thoraxorg."},{"key":"10.1016\/j.addr.2023.114969_b1465","first-page":"621","article-title":"Pulmonary moniliasis treated with nystatin aerosol","volume":"1","author":"Mc","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2023.114969_b1470","doi-asserted-by":"crossref","unstructured":"T.F. Patterson, G.R. Thompson, III, D.W. Denning, J.A. Fishman, S. Hadley, R. Herbrecht, D.P. Kontoyiannis, K.A. Marr, V.A. Morrison, M.H. Nguyen, B.H. Segal, W.J. Steinbach, D.A. Stevens, T.J. Walsh, J.R. Wingard, J.-A.H. Young, J.E. Bennett, Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clin. Infect. Dis. 63 (2016) e1\u2013e60.","DOI":"10.1093\/cid\/ciw326"},{"key":"10.1016\/j.addr.2023.114969_b1475","doi-asserted-by":"crossref","unstructured":"P.G. Pappas, C.A. Kauffman, D.R. Andes, C.J. Clancy, K.A. Marr, L. Ostrosky-Zeichner, A.C. Reboli, M.G. Schuster, J.A. Vazquez, T.J. Walsh, T.E. Zaoutis, J.D. Sobel, Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America, Clin. Infect. Dis. 62 (2015) e1\u2013e50.","DOI":"10.1093\/cid\/civ933"},{"key":"10.1016\/j.addr.2023.114969_b1480","unstructured":"S. Shoham, Aspergillus, in: I. Unbound Medicine (Ed.) Johns Hopkins HIV Guide, 2022."},{"key":"10.1016\/j.addr.2023.114969_b1485","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tim.2010.02.004","article-title":"Therapy for fungal diseases: opportunities and priorities","volume":"18","author":"Denning","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.addr.2023.114969_b1490","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0005-2736(89)90312-X","article-title":"The role of the carboxyl and amino groups of polyene macrolides in their interactions with sterols and their selective toxicity. A 31P-NMR study","volume":"980","author":"Herv\u00e9","year":"1989","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"10.1016\/j.addr.2023.114969_b1495","doi-asserted-by":"crossref","unstructured":"A. Antill\u00f3n, A.H. de Vries, M. Espinosa-Caballero, J.M. Falc\u00f3n-Gonz\u00e1lez, D. Flores Romero, J. Gonz\u00e1lez-Dami\u00e1n, F.E. Jim\u00e9nez-Montejo, A. Le\u00f3n-Buitimea, M. L\u00f3pez-Ortiz, R. Maga\u00f1a, S.J. Marrink, R. Morales-Nava, X. Periole, J. Reyes-Esparza, J. Rodr\u00edguez Lozada, T.M. Santiago-Angelino, M.C. Vargas Gonz\u00e1lez, I. Regla, M. Carrillo-Tripp, M. Fern\u00e1ndez-Zertuche, L. Rodr\u00edguez-Fragoso, I. Ortega-Blake, An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety, PLoS ONE 11 (2016) e0162171.","DOI":"10.1371\/journal.pone.0162171"},{"key":"10.1016\/j.addr.2023.114969_b1500","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1021\/acsinfecdis.0c00068","article-title":"Discovery of amphamide, a drug candidate for the second generation of polyene antibiotics","volume":"6","author":"Tevyashova","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.addr.2023.114969_b1505","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/acsmedchemlett.1c00538","article-title":"Water-soluble nystatin and derivative","volume":"13","author":"Amir","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.addr.2023.114969_b1510","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jcis.2005.02.038","article-title":"N-(1-piperidinepropionyl)amphotericin B methyl ester (PAME)\u2013a new derivative of the antifungal antibiotic amphotericin B: searching for the mechanism of its reduced toxicity","volume":"287","author":"Hac-Wydro","year":"2005","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2023.114969_b1515","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/acsinfecdis.2c00237","article-title":"Semisynthetic amides of polyene antibiotic natamycin","volume":"9","author":"Tevyashova","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.addr.2023.114969_b1520","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/myc.12836","article-title":"Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together","volume":"61","author":"Hoenigl","year":"2018","journal-title":"Mycoses"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23002843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23002843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:24:59Z","timestamp":1777515899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X23002843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":304,"alternative-id":["S0169409X23002843"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2023.114969","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reviving the interest in the versatile drug nystatin: A multitude of strategies to increase its potential as an effective and safe antifungal agent","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2023.114969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114969"}}